Literature DB >> 9695898

Breaking bad news. 3: Encouraging the adoption of best practices.

E M Campbell1, R W Sanson-Fisher.   

Abstract

Steps to encourage clinicians to adopt the best practices for communicating bad news to patients are outlined. First, official, credible guidelines endorsed by key organizations or professional bodies, giving a clear message about the components and importance of the best practices, must be produced. Second, the guidelines should be disseminated; publication in journals or mailing to clinicians is unlikely to be sufficient. Third, clinicians should be provided with feedback on whether their performance meets established standards. This requires acceptable systems to collect valid and reliable performance data. Fourth, clinicians need contingencies for providing best practice care. Fifth, barriers to improvement should be explored and strategies to address them, including interactional skills training, implemented. Continuous quality assurance, commitment, and evaluations will help clinicians use the best practices for breaking bad news to patients.

Entities:  

Mesh:

Year:  1998        PMID: 9695898     DOI: 10.1080/08964289809596383

Source DB:  PubMed          Journal:  Behav Med        ISSN: 0896-4289            Impact factor:   3.104


  2 in total

1.  Pushing up daisies: implicit and explicit language in oncologist-patient communication about death.

Authors:  Keri L Rodriguez; Frank J Gambino; Phyllis Butow; Rebecca Hagerty; Robert M Arnold
Journal:  Support Care Cancer       Date:  2006-09-13       Impact factor: 3.603

2.  Interprofessional communication skills training for serious illness: evaluation of a small-group, simulated patient intervention.

Authors:  Alison M Bays; Ruth A Engelberg; Anthony L Back; Dee W Ford; Lois Downey; Sarah E Shannon; Ardith Z Doorenbos; Barbara Edlund; Phyllis Christianson; Richard W Arnold; Kim O'Connor; Erin K Kross; Lynn F Reinke; Laura Cecere Feemster; Kelly Fryer-Edwards; Stewart C Alexander; James A Tulsky; J Randall Curtis
Journal:  J Palliat Med       Date:  2013-11-01       Impact factor: 2.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.